CMS and FDA unveil a fast track for Medicare access to breakthrough devices

The Centers for Medicare & Medicaid Services (CMS) and the US Food and Drug Administration (FDA) have announced a new regulatory framework designed to accelerate Medicare coverage for certain FDA‑designated Class II and Class III breakthrough devices.

The goal of the new Regulatory Alignment for Predictable and Immediate Device (RAPID)